CSF3 and acute myeloid leukemia: To interrogate whether d715-RHD-derived AML was still dependent on CSF3 administration, we transplanted leukemic cells into tertiary recipients that were subsequently treated with PBS or CSF3 (n = 4 per group; Figure 2J).